Amy Wakeham | executive |
Michael Farrell | executive |
Brett Sandercock | executive |
Dan Hurren | analyst |
Laura Sutcliffe | analyst |
Craig Wong-Pan | analyst |
David Bailey | analyst |
Anthony Petrone | analyst |
Suraj Kalia | analyst |
Margaret Kaczor | analyst |
Gretel Janu | analyst |
Michael Matson | analyst |
Lyanne Harrison | analyst |
Steven Wheen | analyst |
Saul Hadassin | analyst |
Mike Toomey | analyst |
Hello, and welcome to the Q3 Fiscal Year 2024 ResMed Earnings Conference Call. My name is Kevin, and I'll be your operator for today's call. [Operator Instructions] Please note that this conference call is being recorded.
I'll now turn the call over to Amy Wakeham, Chief Investor Relations Officer. Amy, you may begin.